Global Microfluidics Devices Market - 2025-2033

May 2025 | 165 pages | ID: G67DC200AC67EN
DataM Intelligence

US$ 4,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Overview

The global microfluidics devices market reached US$ 7.62 billion in 2024 and is expected to reach US$ 16.20 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033.

Microfluidic devices are specialized tools that control and manipulate small volumes of fluids within microscale channels. They integrate laboratory functions onto a single chip, enabling complex chemical, biological, or physical processes to occur efficiently. These devices offer advantages like reduced reagent consumption, faster reaction times, enhanced analytical sensitivity, and lower operational costs, revolutionizing fields like in-vitro diagnostics, drug discovery, environmental monitoring, and biotechnology research. Their high-throughput testing, portability, and automation potential make them crucial in point-of-care testing, personalized medicine, and lab-on-a-chip technologies.

Market Dynamics: Drivers & Restraints

Rising Demand for Point-of-Care Testing

The global microfluidics devices market is driven by the increasing demand for point-of-care (POC) testing. As healthcare professionals increasingly prioritize faster diagnosis and immediate treatment decisions, microfluidic devices offer rapid, accurate, and portable diagnostic results. These devices miniaturize complex laboratory processes into a single, compact chip, allowing for tests at the patient's site, reducing turnaround times and costs.

For instance, in May 2024, Bio-Rad Laboratories introduced a microfluidic point-of-care diagnostic device, aiming to revolutionize patient care by enabling early disease detection, high sensitivity, and accuracy, while being cost-effective, minimally invasive, and enhancing diagnostic speed in resource-limited settings.

The COVID-19 pandemic has accelerated the adoption of POC devices globally, emphasizing the importance of decentralized testing. Microfluidic-based POC solutions are crucial in expanding healthcare access, particularly in remote and underserved areas. This trend is expected to continue, supporting the growth of the microfluidics devices market.

Complex Manufacturing and Integration Challenges

The global microfluidics devices market is facing challenges due to the complexity of manufacturing and system integration. The intricate design and miniaturization of components make mass production challenging. Integrating microfluidic systems with electronic, optical, and mechanical elements can lead to compatibility issues and technical bottlenecks. These issues result in higher production costs, longer development cycles, and difficulties in standardization, limiting widespread adoption of microfluidic solutions.

Regulatory hurdles associated with device approval and validation further complicate the commercial deployment of innovative microfluidic technologies, restraining overall market growth.

Segment Analysis

The global microfluidics devices market is segmented based on product, material, application, end-user, and region.

Product:

The microfluidic chips segment of the product is expected to dominate the microfluidics devices market with the highest market share.

Microfluidic chips are microfluidic devices that use microscopic channels and chambers to manipulate small amounts of fluids, enabling high-throughput analysis, rapid diagnostics, and precise control over reactions at a microscale, making them crucial in fields like drug discovery, clinical diagnostics, and environmental monitoring.

The microfluidic chips segment is expanding due to increasing demand for point-of-care diagnostics, personalized medicine, miniaturization technologies, and cost-effective laboratory testing. Applications in genomics, proteomics, and drug delivery, along with lab-on-a-chip innovations, are also driving growth. Investment in healthcare R&D and the rise of wearable biosensors and portable diagnostic devices further enhance market potential.

For instance, in July 2024, Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group at Singapore-MIT Alliance for Research and Technology have developed a method to produce clinical doses of viable autologous chimeric antigen receptor (CAR) T-cells in a small automated closed-system microfluidic chip. The research, involving collaborations from Duke-NUS Medical School, IMCB at A*STAR, KK Women's & Children's Hospital, and SGH, is groundbreaking.

Geographical Analysis

North America is expected to hold a significant position in the microfluidics devices market, with the highest market share.

The North American microfluidic devices market is fueled by significant healthcare research investments, a robust pharmaceutical and biotechnology industry, and the rapid adoption of point-of-care diagnostics. The region's advanced technological infrastructure, high prevalence of chronic and infectious diseases, and substantial government funding for life sciences research contribute to market growth. Major players in the U.S. and Canada are also actively collaborating, boosting the market's expansion.

For instance, in 2024, 10,347 TB cases were reported, with a 3.0 case per 100,000 population rate. The increase in case counts (8%) and rates (6%) from 2023 to 2024 was less than the 15% increase from 2022 to 2023, with 34 states and the District of Columbia reporting increases.

Hence, the above instance helps the region to grow due to the development of fast, cost-effective, and point-of-care diagnostic platforms for infectious diseases like TB, and increased disease surveillance and governmental efforts to contain outbreaks.

Competitive Landscape

The major global players in the microfluidics devices market include, Danaher Corporation, Fluigen, Bio-Rad Laboratories, Inc, Illumina, Inc, Micronit Microtechnologies, and Agilent Technologies, and among others.

Key Developments
  • In May 2024, Takara Bio USA, a subsidiary of Takara Bio Inc., launched the Lenti-X Transduction Sponge, a first-to-market microfluidic transduction enhancer that improves in vitro lentivirus-mediated gene delivery techniques. The easy-to-work-around product achieves high transduction efficiency in any cell type, enabling future research in gene and cell therapy.
Why Purchase the Report?
  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global microfluidics devices market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024
  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.
1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product
2.4. Snippet by Material
2.5. Snippet by Application
2.6. Snippet by End User
2.7. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Rising Demand for Point-of-Care Testing
    3.1.1.2. Rise in the Technological Advancements
    3.1.1.3. XX
  3.1.2. Restraints
    3.1.2.1. Complex Manufacturing and Integration Challenges
    3.1.2.2. Regulatory Challenges
    3.1.2.3. XX
  3.1.3. Opportunity
    3.1.3.1. Expansion in Emerging Markets
    3.1.3.2. XX
  3.1.4. Impact Analysis

4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established leaders with largest largest-selling Brand
  4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
  4.5.1. North America
  4.5.2. Europe
  4.5.3. Asia Pacific
  4.5.4. South America
  4.5.5. Middle East & Africa
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders

5. GLOBAL MICROFLUIDICS DEVICES MARKET BY PRODUCT

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  5.1.2. Market Attractiveness Index, By Product
5.2. Microfluidic Chips*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Microfluidic Sensors
5.4. Microfluidic Pumps and Valves
5.5. Others

6. GLOBAL MICROFLUIDICS DEVICES MARKET BY MATERIAL

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  6.1.2. Market Attractiveness Index, By Material
6.2. Silicon and Glass*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Paper
6.4. Polymers
6.5. Hydrogels
6.6. Others

7. GLOBAL MICROFLUIDICS DEVICES MARKET, BY APPLICATION

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  7.1.2. Market Attractiveness Index, By Application
7.2. In-vitro Diagnostics (IVD)*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Pharmaceutical and Life Science Research
7.4. Drug Delivery
7.5. Others

8. GLOBAL MICROFLUIDICS DEVICES MARKET, BY END USER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals and Diagnostic Centers*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Academic and Research Institutes
8.4. Pharmaceutical and Biotechnology Companies
8.5. Others

9. MICROFLUIDICS DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.7.1. U.S.
    9.2.7.2. Canada
    9.2.7.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.7.1. Germany
    9.3.7.2. U.K.
    9.3.7.3. France
    9.3.7.4. Spain
    9.3.7.5. Italy
    9.3.7.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.7.1. Brazil
    9.4.7.2. Argentina
    9.4.7.3. Rest of South America
9.5. Asia-Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.7.1. China
    9.5.7.2. India
    9.5.7.3. Japan
    9.5.7.4. South Korea
    9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking

11. COMPANY PROFILES

11.1. Danaher Corporation*
  11.1.1. Company Overview
  11.1.2. Product Portfolio
    11.1.2.1. Product Description
    11.1.2.2. Product Key Performance Indicators (KPIs)
    11.1.2.3. Historic and Forecasted Product Sales
    11.1.2.4. Product Sales Volume
  11.1.3. Financial Overview
    11.1.3.1. Company Revenue
    11.1.3.2. Geographical Revenue Shares
    11.1.3.3. Revenue Forecasts
  11.1.4. Key Developments
    11.1.4.1. Mergers & Acquisitions
    11.1.4.2. Key Product Development Activities
    11.1.4.3. Regulatory Approvals, etc.
  11.1.5. SWOT Analysis
11.2. Fluigen
11.3. Bio-Rad Laboratories, Inc
11.4. Illumina, Inc
11.5. Micronit Microtechnologies
11.6. Agilent Technologies Inc
LIST NOT EXHAUSTIVE

12. ASSUMPTIONS AND RESEARCH METHODOLOGY

12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us

LIST OF TABLES

Table 1 Global Microfluidics Devices Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Microfluidics Devices Market Value, By Material, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Microfluidics Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Microfluidics Devices Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Microfluidics Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Microfluidics Devices Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Microfluidics Devices Market Value, By Product, 2022-2033 (US$ Billion)
Table 8 Global Microfluidics Devices Market Value, By Material, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Microfluidics Devices Market Value, By Material, 2022-2033 (US$ Billion)
Table 10 Global Microfluidics Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Microfluidics Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Microfluidics Devices Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Microfluidics Devices Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Microfluidics Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Microfluidics Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Microfluidics Devices Market Value, By Product, 2022-2033 (US$ Billion)
Table 17 North America Microfluidics Devices Market Value, By Material, 2022-2033 (US$ Billion)
Table 18 North America Microfluidics Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Microfluidics Devices Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Microfluidics Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 South America Microfluidics Devices Market Value, By Product, 2022-2033 (US$ Billion)
Table 22 South America Microfluidics Devices Market Value, By Material, 2022-2033 (US$ Billion)
Table 23 South America Microfluidics Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 South America Microfluidics Devices Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 South America Microfluidics Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Microfluidics Devices Market Value, By Product, 2022-2033 (US$ Billion)
Table 27 Europe Microfluidics Devices Market Value, By Material, 2022-2033 (US$ Billion)
Table 28 Europe Microfluidics Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Europe Microfluidics Devices Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Europe Microfluidics Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Asia-Pacific Microfluidics Devices Market Value, By Product, 2022-2033 (US$ Billion)
Table 32 Asia-Pacific Microfluidics Devices Market Value, By Material, 2022-2033 (US$ Billion)
Table 33 Asia-Pacific Microfluidics Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 Asia-Pacific Microfluidics Devices Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 Asia-Pacific Microfluidics Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Microfluidics Devices Market Value, By Product, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Microfluidics Devices Market Value, By Material, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Microfluidics Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Microfluidics Devices Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Microfluidics Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Danaher Corporation: Overview
Table 42 Danaher Corporation: Product Portfolio
Table 43 Danaher Corporation: Key Developments
Table 44 Fluigen: Overview
Table 45 Fluigen: Product Portfolio
Table 46 Fluigen: Key Developments
Table 47 Bio-Rad Laboratories, Inc.: Overview
Table 48 Bio-Rad Laboratories, Inc.: Product Portfolio
Table 49 Bio-Rad Laboratories, Inc.: Key Developments
Table 50 Illumina, Inc.: Overview
Table 51 Illumina, Inc.: Product Portfolio
Table 52 Illumina, Inc.: Key Developments
Table 53 Micronit Microtechnologies: Overview
Table 54 Micronit Microtechnologies: Product Portfolio
Table 55 Micronit Microtechnologies: Key Developments
Table 56: Agilent Technologies: Overview
Table 57: Agilent Technologies: Product Portfolio
Table 58: Agilent Technologies: Key Developments
Table 59: Overview
Table 60: Product Portfolio
Table 61: Key Developments

LIST OF FIGURES

Figure 1 Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Microfluidics Devices Market Share, By Product, 2024 & 2033 (%)
Figure 3 Global Microfluidics Devices Market Share, By Material, 2024 & 2033 (%)
Figure 4 Global Microfluidics Devices Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Microfluidics Devices Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Microfluidics Devices Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Microfluidics Devices Market Y-o-Y Growth, By Product, 2023-2033 (%)
Figure 8 Microfluidic Chips Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Microfluidic Sensors Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Microfluidic Pumps and Valves Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 11: Other Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Microfluidics Devices Market Y-o-Y Growth, By Material, 2023-2033 (%)
Figure 13 Polymers Material in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Glass Material in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Silicon Material in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Other Materials in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Microfluidics Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 18 In-vitro Diagnostics (IVD) Application in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Pharmaceutical and Life Science Research Application in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Drug Delivery Application in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 21: Others Application in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Microfluidics Devices Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 23 Hospitals and Diagnostic Centers End User in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 24 Academic and Research Institutes End User in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 Pharmaceutical and Biotechnology Companies End User in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 26: Other End Users in Global Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Microfluidics Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 28 North America Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 29 North America Microfluidics Devices Market Share, By Product, 2024 & 2033 (%)
Figure 30 North America Microfluidics Devices Market Share, By Material, 2024 & 2033 (%)
Figure 31 North America Microfluidics Devices Market Share, By Application, 2024 & 2033 (%)
Figure 32 North America Microfluidics Devices Market Share, By End User, 2024 & 2033 (%)
Figure 33 North America Microfluidics Devices Market Share, By Country, 2024 & 2033 (%)
Figure 34 South America Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 35 South America Microfluidics Devices Market Share, By Product, 2024 & 2033 (%)
Figure 36 South America Microfluidics Devices Market Share, By Material, 2024 & 2033 (%)
Figure 37 South America Microfluidics Devices Market Share, By Application, 2024 & 2033 (%)
Figure 38 South America Microfluidics Devices Market Share, By End User, 2024 & 2033 (%)
Figure 39 South America Microfluidics Devices Market Share, By Country, 2024 & 2033 (%)
Figure 40 Europe Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 41 Europe Microfluidics Devices Market Share, By Product, 2024 & 2033 (%)
Figure 42 Europe Microfluidics Devices Market Share, By Material, 2024 & 2033 (%)
Figure 43 Europe Microfluidics Devices Market Share, By Application, 2024 & 2033 (%)
Figure 44 Europe Microfluidics Devices Market Share, By End User, 2024 & 2033 (%)
Figure 45 Europe Microfluidics Devices Market Share, By Country, 2024 & 2033 (%)
Figure 46 Asia-Pacific Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 47 Asia-Pacific Microfluidics Devices Market Share, By Product, 2024 & 2033 (%)
Figure 48 Asia-Pacific Microfluidics Devices Market Share, By Material, 2024 & 2033 (%)
Figure 49 Asia-Pacific Microfluidics Devices Market Share, By Application, 2024 & 2033 (%)
Figure 50 Asia-Pacific Microfluidics Devices Market Share, By End User, 2024 & 2033 (%)
Figure 51 Asia-Pacific Microfluidics Devices Market Share, By Country, 2024 & 2033 (%)
Figure 52 Middle East and Africa Microfluidics Devices Market Value, 2022-2033 (US$ Billion)
Figure 53 Middle East and Africa Microfluidics Devices Market Share, By Product, 2024 & 2033 (%)
Figure 54 Middle East and Africa Microfluidics Devices Market Share, By Material, 2024 & 2033 (%)
Figure 55 Middle East and Africa Microfluidics Devices Market Share, By Application, 2024 & 2033 (%)
Figure 56 Middle East and Africa Microfluidics Devices Market Share, By End User, 2024 & 2033 (%)
Figure 57 Danaher Corporation: Financials
Figure 58 Fluigen: Financials
Figure 59 Bio-Rad Laboratories, Inc.: Financials
Figure 60 Illumina, Inc.: Financials
Figure 61 Micronit Microtechnologies: Financials
Figure 62: Agilent Technologies: Financials
Figure 63: Financials


More Publications